Source:http://linkedlifedata.com/resource/pubmed/id/21209445
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2011-1-6
|
pubmed:abstractText |
We evaluated the effects of implementing a value-based insurance design program for patients with diabetes in two groups within a single firm. One group participated in disease management; the other did not. We matched members of the two groups to similar enrollees within the company that did not offer the value-based program. We found that participation in both value-based insurance design and disease management resulted in sustained improvement over time. Use of diabetes medications increased 6.5 percent over three years. Adherence to diabetes medical guidelines also increased, producing a return on investment of $1.33 saved for every dollar spent during a three-year follow-up period.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1544-5208
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
100-8
|
pubmed:meshHeading |
pubmed-meshheading:21209445-Cost Savings,
pubmed-meshheading:21209445-Deductibles and Coinsurance,
pubmed-meshheading:21209445-Diabetes Mellitus,
pubmed-meshheading:21209445-Disease Management,
pubmed-meshheading:21209445-Female,
pubmed-meshheading:21209445-Humans,
pubmed-meshheading:21209445-Hypoglycemic Agents,
pubmed-meshheading:21209445-Insurance, Health,
pubmed-meshheading:21209445-Male,
pubmed-meshheading:21209445-Middle Aged,
pubmed-meshheading:21209445-Models, Econometric,
pubmed-meshheading:21209445-Patient Compliance
|
pubmed:year |
2011
|
pubmed:articleTitle |
Value-based insurance plus disease management increased medication use and produced savings.
|
pubmed:affiliation |
Thomson Reuters, Ann Arbor, Michigan, USA. teresa.gibson@thomsonreuters.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|